RE:RE:RE:More great news!
I just wanted to share this tidbit. Briacillian - one dose treatment as effective as seven dose treatment of Daptomycin. "Its turned out to be one of the shrewdest biotech deals in recent memory. After the failed trial, Cubist figured out what went wrong, and won FDA approval of daptomycin in 2003. Sold as Cubicin, the drug now generates close to $1 billion annually, and has become a mainstay for MRSA skin infections and other infections"